About Fundación Oftalmológica de Santander - FOSCAL
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Fundación Oftalmológica de Santander - FOSCAL
During the past decade, Fundación Oftalmológica de Santander - FOSCAL conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 4 clinical trials were completed, i.e. on
average, 30.8% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Fundación Oftalmológica de Santander - FOSCAL" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Takeda" with 2 trials
sponsored, "Allergan" with 1 trials sponsored, "Arbor Pharmaceuticals, Inc." with 1 trials sponsored and "Baxalta now part of Shire"
with 1 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Fundación Oftalmológica de Santander - FOSCAL"
#1 collaborator was "Baxalta Innovations GmbH, now part of Shire" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Heart and Stroke Foundation of Ontario" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Fundación Oftalmológica de Santander - FOSCAL
According to Clinical.Site data, the most researched conditions in "Fundación Oftalmológica de Santander - FOSCAL" are
"Multiple Myeloma" (2 trials), "Ocular Hypertension" (2 trials), "Acute Respiratory Infection" (1 trials), "COVID-19" (1 trials) and "Cancer" (1 trials). Many other conditions were trialed in "Fundación Oftalmológica de Santander - FOSCAL" in a lesser frequency.
Clinical Trials Intervention Types at Fundación Oftalmológica de Santander - FOSCAL
Most popular intervention types in "Fundación Oftalmológica de Santander - FOSCAL" are "Drug" (9 trials), "Other" (4 trials), "Biological" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "ADVATE" (1 trials), "ADYNOVI" (1 trials), "Active Comparator: Timolol 0.5%" (1 trials) and "Ad26.COV2.S" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Fundación Oftalmológica de Santander - FOSCAL
The vast majority of trials in "Fundación Oftalmológica de Santander - FOSCAL" are
16 trials for "All" genders.
Clinical Trials Status at Fundación Oftalmológica de Santander - FOSCAL
Currently, there are NaN active trials in "Fundación Oftalmológica de Santander - FOSCAL".
undefined are not yet recruiting,
4 are recruiting,
4 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 6 completed trials in Fundación Oftalmológica de Santander - FOSCAL,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Fundación Oftalmológica de Santander - FOSCAL, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".